亚洲一区二区三区免费av在线 ,少妇宾馆粉嫩10p,99热国产在线精品99

產(chǎn)品詳情

查看大圖

產(chǎn)品名稱：HTB-172 NCI-H209 人小細(xì)胞肺癌細(xì)胞
產(chǎn)品型號：HTB-172
產(chǎn)品廠商：美國標(biāo)準(zhǔn)生物品收藏中心（ATCC）
產(chǎn)品價格：0
折扣價格：0
產(chǎn)品文檔：

你添加了1件商品查看購物車

簡單介紹：

HTB-172 NCI-H209 人小細(xì)胞肺癌細(xì)胞，原代細(xì)胞|細(xì)胞系|細(xì)胞株|菌種；細(xì)胞庫管理規(guī)范，提供的細(xì)胞株背景清楚，提供參考文獻(xiàn)和培養(yǎng)條件！

詳情介紹：

HTB-172 NCI-H209 人小細(xì)胞肺癌細(xì)胞

ATCC^® Number:

HTB-172?

Price:

$338.00

Designations:	NCI-H209 [H209]
Depositors:	AF Gazdar, JD Minna
Biosafety Level:	1
Shipped:	frozen
Medium & Serum:	See Propagation
Growth Properties:	aggregates in suspension
Organism:	Homo sapiens (human)
Morphology:	epithelial
Source:	Organ: lung Disease: carcinoma; small cell lung cancer Derived from metastatic site: bone marrow
Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Tumorigenic:	Yes
Oncogene:	pRB + (abnormal, RB1)
DNA Profile (STR):	Amelogenin: X,Y CSF1PO: 11 D13S317: 11 D16S539: 9,12 D5S818: 12 D7S820: 9 THO1: 7,9 TPOX: 8 vWA: 18,19
Cytogenetic Analysis:	This is a hyperdiploid human cell line., The modal chromosome number is 49, occurring at 28% with a frequency of higher ploidies of 1.3%. Ten to eleven markers were common to all cells including: der(1)t(1;3)(p22;p21), del(6)(q21), t(8q18q), del(12)(q13), der(14)t(14;?)(q32;?)., All had a single copy per cell. About 6 other markers were found, but they occurred only once in all metaphases karyotyped. Neither HSR nor DM were detected., Structurally normal B group chromosomes were not detected. All C group chromosomes were paired. A single copy of both the X and Y was found in all cells.
Isoenzymes:	AK-1, 1 ES-D, 1 G6PD, B Me-2, 0 PGM1, 1-2 PGM3, 1
Gender:	male
Ethnicity:	Caucasian
Comments:	The NCI-H209 cell line was derived by A.F. Gazdar and associates in 1979 from the bone marrow of a patient with small cell cancer of the lung. The bone marrow specimen was taken prior to therapy. The line is a classic SCLC cell line which expresses elevated levels of four biochemical markers (neuron specific enolase, brain isoenzyme of creatine kinase, L-DOPA decarboxylase and bombesin-like immunoreactivity. C-myc DNA sequences are not amplified. No gross structural DNA abnormalities were detected. The line produces normal amounts of p53 mRNA relative to normal lung. This is a cell line that grows as large aggregates in suspension. Only the aggregates are viable, but no meaningful viability percentage can be measured. The medium will normally contain large amounts of cell debris. The cells express an aberrant form of RB1 that is not phosphorylated, apparently due to a single point mutation at codon 706 (Cys -> Phe).
Propagation:	ATCC complete growth medium: Iscove's modified Dulbecco's medium, 90%; fetal bovine serum, 10% - OR - RPMI 1640 medium, 90%; fetal bovine serum, 10%
Subculturing:	Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:3 is recommended Medium Renewal: 2 to 3 times per week The line should be subcultured by dilution with fresh medium. Alternatively, the clusters may be collected by centrifugation and resuspended in fresh medium.
Preservation:	Culture medium, 95%; DMSO, 5%
Related Products:	normal (or near-normal) cell line established from the same patient:ATCC CRL-5948
References:	1805: Little CD, et al. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306: 194-196, 1983. PubMed: 6646201 1806: Takahashi T, et al. p53: A frequent target for genetic abnormalities in lung cancer. Science 246: 491-494, 1989. PubMed: 2554494 23056: Carney DN, et al. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 45: 2913-2923, 1985. PubMed: 2985257 23080: Hensel CH, et al. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res. 50: 3067-3072, 1990. PubMed: 2159370 23320: Kaye FJ, et al. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc. Natl. Acad. Sci. USA 87: 6922-6926, 1990. PubMed: 2168563 32276: Cairns P, et al. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions. Cancer Res. 57: 5356-5359, 1997. PubMed: 9393760 32287: Rostomily RC, et al. Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. Cancer Res. 57: 3526-3531, 1997. PubMed: 9270024

姓名：

電話：

Email：

您的需求：

滬公網(wǎng)安備 31010902002429號

產(chǎn)品名稱：HTB-172 NCI-H209 人小細(xì)胞肺癌細(xì)胞